
|Articles|January 15, 2003
Study evaluates role of steroids, system on PME
Sunnyvale, CA-Oculex Pharmaceuticals Inc. has completed patient enrollment in its phase II clinical trial of its lead product, Posurdex, for the treatment of persistent macular edema (PME).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement

















